TMTakahiro Mitani

Takahiro Mitani

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Takahiro Mitani has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Coordinated Membrane Deformation Driven by a Minimal Set of Spiroplasma MreB Isoforms

    by Takahiro Mitani, Taiki Nishimura, Hana Kiyama, Ahsan Ali, Masahito Hayashi, Kingo Takiguchi, Makoto Miyata, Ikuko Fujiwara

    Spiroplasma are wall-less helical bacteria that swim by switching the handedness of their helices. In most bacteria, MreB, a bacterial actin, forms relatively static filaments beneath the membrane to organize cell wall synthesis. In contrast, Spiroplasma eriocheiris encodes five MreB isoforms (SpeMreBs), and swimming requires a pair of isoforms, SpeMreB5 together with SpeMreB4 (or the related isoform SpeMreB1) (1) Yet how these MreBs generate force and membrane deformation remains unclear. To examine the membrane-deforming activities of SpeMreBs, we demonstrated a simple reconstitution system using the non-motile synthetic bacterium JCVI-syn3B and purified SpeMreBs expressed in Escherichia coli . Lysates of syn3B expressing SpeMreB5 deformed liposomes in a concentration-dependent manner. In contrast, lysates co-expressing both SpeMreB5 and SpeMreB4 showed a plateau in the frequency of deformation, suggesting that SpeMreB4 suppresses membrane deformation driven by SpeMreB5. Deformed liposomes exhibited either fluctuating or stable behaviors. ATP depletion changed both the frequency and behavior of deformation, indicating that membrane remodeling depends on the nucleotide state of SpeMreBs. Reconstitution with purified SpeMreBs from E. coli confirmed that SpeMreB5 alone deforms membranes, whereas SpeMreB1, a member of the same class as SpeMreB4, suppresses deformation. These results suggest that membrane shape in Spiroplasma is dynamically regulated by antagonistic interactions among isoforms of SpeMreBs isoforms and their nucleotide-dependent assembly states.

  • Open Access

    Microscopic and structural observations of actin filament capping and severing by cytochalasin D

    by Takahiro Mitani, Shuichi Takeda, Toshiro Oda, Akihiro Narita, Yuichiro Maéda, Hajime Honda, Ikuko Fujiwara

    Cytochalasin D (CytoD), a widely used actin inhibitor, is typically employed in cell studies as a simple barbed end capper. However, accumulating evidence suggests broader effects on actin dynamics. We addressed this by observing single actin filaments using total internal reflection fluorescence microscopy. Our depolymerization assay confirmed that, at nanomolar concentrations, CytoD tightly caps barbed ends. The K 1/2 for inhibition was 4.1 nM, consistent with previous bulk measurements, and our approach revealed a capping duration of ~2 min. In polymerization assays, nanomolar CytoD completely suppressed barbed end elongation. Interestingly, at subnanomolar concentrations, CytoD caps barbed ends only transiently, rapidly associating and dissociating under both polymerizing and depolymerizing conditions. We interpreted this contradictory behavior as arising from differences in binding modes: capping one strand (fast dissociation) or both strands (slow dissociation). CytoD severs actin filaments at micromolar levels, a concentration range commonly used in cell biological studies. Although the severing rate is slower than cofilin, its higher frequency leads to filament fragmentation. Severing activity was suppressed by inorganic phosphate or cofilin. Our crystal structure of CytoD bound to filamentous conformation (F-form) actin showed that CytoD fits better in the hydrophobic cleft of F-form actin than monomeric conformation actin, explaining its preference for barbed end subunits. CytoD prevents barbed end depolymerization by stabilizing the terminal subunits in the F-form, which is supported by our MD simulations. These findings reveal the molecular mechanisms by which CytoD modulates actin dynamics and highlight the need for careful dosage control when treating cells with CytoD.